Oxford Textbook of Psoriatic Arthritis (Oxford Textbooks in Rheumatology)

個数:

Oxford Textbook of Psoriatic Arthritis (Oxford Textbooks in Rheumatology)

  • 在庫がございません。海外の書籍取次会社を通じて出版社等からお取り寄せいたします。
    通常6~9週間ほどで発送の見込みですが、商品によってはさらに時間がかかることもございます。
    重要ご説明事項
    1. 納期遅延や、ご入手不能となる場合がございます。
    2. 複数冊ご注文の場合は、ご注文数量が揃ってからまとめて発送いたします。
    3. 美品のご指定は承りかねます。

    ●3Dセキュア導入とクレジットカードによるお支払いについて
  • 【入荷遅延について】
    世界情勢の影響により、海外からお取り寄せとなる洋書・洋古書の入荷が、表示している標準的な納期よりも遅延する場合がございます。
    おそれいりますが、あらかじめご了承くださいますようお願い申し上げます。
  • ◆画像の表紙や帯等は実物とは異なる場合があります。
  • ◆ウェブストアでの洋書販売価格は、弊社店舗等での販売価格とは異なります。
    また、洋書販売価格は、ご注文確定時点での日本円価格となります。
    ご注文確定後に、同じ洋書の販売価格が変動しても、それは反映されません。
  • 製本 Hardcover:ハードカバー版/ページ数 336 p.
  • 言語 ENG
  • 商品コード 9780198737582
  • DDC分類 616.7227

Full Description

Psoriatic arthritis, or PsA, is now acknowledged the second most prevalent and important inflammatory arthropathy worldwide. The addition of this new textbook on PsA is a fitting and important inclusion to the Oxford Textbooks in Rheumatology series, written to reflect the significant advances in the field in recent years.

With the recent advances in the understanding of pathogenesis, and the development of novel therapies, the Oxford Textbook of Psoriatic Arthritis provides a comprehensive overview of the disease. Each chapter is written by leading clinicians and scientists in the field of psoriatic arthritis, to provide a contemporary view of PsA, and a look into the future directions of research. Covering everything from epidemiology and diagnosis to genetics and pathology, detailed sections on treatment and outcomes provide an invaluable resource for the clinician. The book is also highly illustrated with both clinical images such as x-rays and histological photographs to aid clinical knowledge, and diagrams of the immunology and genetics that underlie the disease.

Practical and all-inclusive, with summary boxes to distil the most important information, the Oxford Textbook of Psoriatic Arthritis will prove an invaluable resource for rheumatologists, dermatologists, trainees, and all members of the multidisciplinary team who are interested in recent advances in PsA.

Contents

Introduction
1: Dafna Gladman and Oliver FitzGerald: Introduction to Psoriatic Arthritis
Epidemiology
2: Joel Gelfand and Junko Takeshita: Epidemiology of Psoriasis
3: Elaine Husni and Madonna Michael: Epidemiology of Psoriatic Arthritis
Pathogenesis
4: Kurt De Vlam: Overview of Psoriatic Arthritis Pathogenesis
5: Philip E. Stuart, Lam C. Tsoi, Caely A. Hambro, and James T. Elder: Genetics of Psoriasis
6: Robert Winchester and Proton Rahman: Genetics of Psoriatic Arthritis
7: Bruce Kirkham: Immunology and Cytokine Pathways
8: Rik Lories: Mechanisms of bone destruction and proliferation
Clinical features
9: Cheryl F. Rosen and Brian Kirby: Psoriasis and Nail
10: Raffaele Scarpa, Francesco Caso, Luisa Costa, Rosario Peluso, Nicola Matteo Dario Di Minno, and Antonio Del Puente: Peripheral arthritis
11: Juan D. Cañete and Julio Ramírez: Enthesitis
12: Ignazio Olivieri, Enrico Scarano, Salvatore D'Angelo, Carlo Palazzi, and Angela Padula: Dactylitis
13: Ennio Lubrano: Axial disease
14: Filip Van den Bosch: Extra-articular, extra-skin disease
15: Muhammad Haroon: Co-morbidities
Imaging
16: Neil McHugh and William Tillett: Plain radiography
17: Gurjit Kaeley: Ultrasound
18: Dennis McGonagle and Iris Eshed: MRI
19: Georg Schett and Camille Figueiredo: MicroCT
Diagnosis and classification
20: Laura Coates and William Taylor: Diagnosis and classification criteria
Outcome and biomarkers
21: Lihi Eder: Clinical course and outcome
22: Vinod Chandran and Katerina Oikonomopoulou: Biomarkers of psoriatic arthritis outcome
Domains, instruments, and composite scores
23: Alberto Cauli: Domains and instruments
24: Laure Gossec, Maarten de Wit, and Tania Gudu: Patient-related outcome measures
25: Philip Helliwell: Composite scores
Treatment
26: Alice Gottlieb, Ami Saraiya, and Deep Joshipura: Psoriasis treatment
27: Enrique Soriano and Laura Acosta Felquer: Approach to management and symptomatic (including non-pharmacologic) management of PsA
28: Frank Behrens, Michaela Koehm, and Michael J. Pamham: Synthetic DMARDS
29: Arthur Kavanaugh and Tristan Boyd: Biologic DMARDS (TNFi)
30: Philip Mease: Non-TNF Biologic DMARDS
31: Laura Coates, Arthur Kavanaugh, and Christopher Ritchlin: Treatment algorithm and treat to target
Future directions
32: Dafna Gladman and Oliver FitzGerald: Future directions

最近チェックした商品